Bloom Standard

Bloom Standard is a private clinical-stage medtech company developing autonomous, AI-enabled ultrasound systems intended to expand access to essential imaging in low-resource and front-line care settings. Its lead product, the RAPIDscan Ultrasound System, is a hands-free, wearable/self-driving ultrasound platform that combines automated image acquisition with onboard AI-based interpretation and decision support. The company is focused on earlier screening and triage for cardiac, pulmonary, obstetric, maternal, newborn, and child health use cases, particularly where trained sonographers and conventional ultrasound infrastructure are scarce. Bloom Standard has received FDA Breakthrough Device Designation for RAPIDscan, but the device remains investigational and pending FDA authorization or clearance. The company positions its technology as a lower-cost, scalable alternative to conventional ultrasound for primary care, maternity, humanitarian, and underserved settings.